{
  "context": {
    "rules": [
      "Rule1: Provided that drug Alpha has a patent in region Zeta, then drug Alpha is licensed to company Beta.",
      "Rule2: Either drug Alpha has a patent in region Zeta, or drug Alpha is a generic drug.",
      "Rule3: Drug Alpha is safe, or drug Alpha has a successful efficacy trial.",
      "Rule4: Under the condition that drug Alpha has a successful efficacy trial, drug Alpha is effective against disease Gamma.",
      "Rule5: Whenever drug Alpha has severe side effects, it is not the case that drug Alpha is recalled.",
      "Rule6: If drug Alpha is under investigation by the regulatory agency, then drug Alpha has severe side effects.",
      "Rule7: Provided that drug Alpha’s trial is suspended, drug Alpha is under investigation by the regulatory agency.",
      "Rule8: Whenever drug Alpha is licensed to company Beta, then drug Alpha is produced by company Beta.",
      "Rule9: If drug Alpha is licensed to company Beta, then drug Alpha is marketed by company Beta.",
      "Rule10: Either company Beta enforces exclusivity of the license, or the license agreement requires exclusivity.",
      "Rule11: Drug Alpha is approved in region Zeta, or it is not the case that drug Alpha has a patent in region Zeta.",
      "Rule12: If the license agreement requires exclusivity, then whenever drug Alpha is marketed by company Beta, drug Alpha is not produced by company Beta.",
      "Rule13: Provided that the license agreement is valid, then if company Beta enforces exclusivity of the license, it follows that if drug Alpha is marketed by company Beta, then drug Alpha is not produced by company Beta.",
      "Rule14: Study Theta is funded, or study Theta is published, or drug Alpha is not approved in region Zeta.",
      "Rule15: Study Theta has positive results, or study Theta is completed, or study Theta is not funded.",
      "Rule16: Study Theta is reviewed by the regulatory agency, or study Theta does not have positive results.",
      "Rule17: If drug Alpha is effective against disease Gamma, then drug Alpha is not available on the market.",
      "Rule18: If it is not the case that if drug Alpha is safe then drug Alpha is effective against disease Gamma, then drug Alpha is recalled.",
      "Rule19: If it is not the case that provided drug Alpha is safe then drug Alpha is effective against disease Gamma, then drug Alpha’s trial is suspended.",
      "Rule20: Provided that drug Alpha is not a generic drug, then drug Alpha is available on the market."
    ],
    "facts": [
      "Fact1: The license agreement is valid.",
      "Fact2: Study Theta is not published.",
      "Fact3: Study Theta is not completed.",
      "Fact4: Study Theta is not reviewed by the regulatory agency."
    ]
  },
  "question": "Drug Alpha is a generic drug."
}